A new chapter in scientific leadership and the future of longevity.
Anera Life Inc. is proud to announce that Dr. Andrew J.M. Willoughby, DMD, LVIF, FAGD, FICOI, FICCMO, FAACFP, MICCMO, has been appointed President of Anera Life Inc., marking a major milestone in the evolution of the company and its long-term mission to build a clinically credible, scientifically governed longevity ecosystem.
Dr. Willoughby first joined Anera as Senior Clinical Advisor, bringing over 37 years of clinical experience, more than 90 patents, decades of innovation in nanometallic medicine, and scientific leadership spanning epigenetics, regenerative therapeutics, biological dentistry, neuromuscular science, and advanced biomaterials.
His thinking bridges the worlds of clinical practice, molecular biology, and systems design, the exact intersection where true healthspan innovation must emerge.
Today, with his appointment as President, that vision expands.
A Leader Built for the Future of Human Health
Dr. Willoughby is not a traditional clinical advisor. He is an architect, someone who understands how biology, physics, and technology meet inside the human body. His work integrates:
- nanometallic biomedical science
- mitochondrial and epigenetic signaling
- biomechanical neurology and craniofacial physiology
- regenerative biomaterials and cellular repair
- personalized, data-driven health protocols
- decades of clinical application inside real patients
For Anera Life, this is not only an executive promotion, it’s an elevation into a new scientific era.
Anera’s Thesis: Longevity Must Be Built Like a System
The future of longevity will not be built on isolated supplements or marketing trends. It must be an integrated ecosystem products, protocols, data, biomarker feedback, scientific governance, and clinical insight working together to support cellular resilience and extend healthspan.
Dr. Willoughby will now lead the strategic and scientific architecture of that ecosystem, including:
- directing the Scientific Advisory Board
- overseeing clinical validation and regulatory strategy
- guiding new formulation pathways and R&D
- advancing biomarker-guided product development
- establishing scientific governance standards
- expanding relationships with researchers, physicians, and institutions
- formalizing Anera’s long-term ecosystem blueprint for global health
Every decision from ingredient selection to nano-delivery systems, from research partnerships to future therapeutic models will be shaped through a scientific lens under Dr. Willoughby’s leadership.
From Pain to Purpose Now Strategy to Scale
Anera began as a personal mission. A bottle of NMN changed a life, and that moment of relief became a purpose: to help heal humanity through real longevity science, not hype.
That personal turning point belongs to Anera’s Founder & CEO, Truc Tran, who built the company from the ground up after uncovering the impact that cellular health and mitochondrial repair had on his own wellbeing. Guided by a relentless commitment to truth, scientific integrity, and global accessibility, he now leads Anera’s vision, strategic partnerships, and expansion into a complete longevity ecosystem designed for real-world impact.
Connect with Truc on LinkedIn
As we scale globally supported by clinical advisors, scientific partners, and collaborators across research, medicine, and biology the appointment of Dr. Willoughby as President ensures the company grows with scientific discipline, clinical excellence, and a long-term framework rooted in evidence and mission.
“I believe human health is at an inflection point,” said Dr. Willoughby
“Longevity must be understood as a living system biochemical, electrical, neurological, metabolic, and behavioral. Anera is building the type of company capable of tackling that complexity, and I am honored to help lead its next phase.”
Anera’s Commitment
We will build a longevity company with the same seriousness and scientific rigor one would expect from biotech or advanced medicine yet grounded in accessibility, integrity, and human care.
Our founders and our leadership share one unshakable belief:
Longevity is not just about adding years. It’s about restoring capacity, dignity, and the ability to live fully for life.
With Dr. Andrew Willoughby as President, Anera now moves forward with a scientific foundation worthy of that goal.
This is the future we are building. And this is the beginning of that future being led from within.
